Sharps Compliance (NASDAQ: SMED)
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-10-26 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-22 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Sharps Compliance (NASDAQ: SMED) through any online brokerage.
Other companies in Sharps Compliance’s space includes: Sema4 Holdings (NASDAQ:SMFR), Aveanna Healthcare Hldgs (NASDAQ:AVAH), ATI Physical Therapy (NYSE:ATIP), Star Equity Hldgs (NASDAQ:STRR) and Novo Integrated Sciences (NASDAQ:NVOS).
The latest price target for Sharps Compliance (NASDAQ: SMED) was reported by Barrington Research on Tuesday, June 28, 2022. The analyst firm set a price target for 6.00 expecting SMED to fall to within 12 months (a possible -30.80% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Sharps Compliance (NASDAQ: SMED) is $8.67 last updated August 9, 2022, 8:00 PM UTC.
There are no upcoming dividends for Sharps Compliance.
Sharps Compliance’s Q1 earnings are confirmed for Wednesday, October 26, 2022.
There is no upcoming split for Sharps Compliance.
Sharps Compliance is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.